Name
BOLD
Alternate names
None
Primary Site
Colorectal, skin
Histology
Melanoma
Radiation
None
Remarks
None
Drugs for BOLD
Name
Alternate Names
Deticene
Detimedac
Dimethyl-triazeno-imidazole-carboxamide
DTIC-Dome
Fauldetic
Imidazole carboxamide
WR-139007
Abbreviations
DIC
DTIC
ICDT
ICT
Category
Chemotherapy
Subcategory
Antimetabolite
Nonclassic alkylating agent
NSC Number
45388
045388
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo
Abbreviations
BLE
BLEO
BLM
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
125066
Primary Site
Histology
None
Remarks
FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded